Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer

Support Care Cancer. 2023 Apr 14;31(5):268. doi: 10.1007/s00520-023-07736-0.

Abstract

Purpose: Little is known about whether baseline health-related quality of life (HRQoL) scores also could predict occurrence radiotherapy-related toxicities, which we aim to assess in this study.

Methods: This study analyzed data from 200 patients enrolled in randomized study investigating the utility of HRQoL. HRQOL was assessed at baseline and during follow up using QLQ-C30 questionnaire and major toxicity was considered as adverse event ≥ 3 according to NCI-CTCAE classification. Cox regressions adjusting for clinical and sociodemographic data were used to assess prognostic significance of HRQOL scores.

Results: In multivariable analyses adjusted on clinical and sociodemographic data, every 10-point improvement in physical (HR = 0.74), role (HR = 0.87) and social (HR = 0.88) functioning was associated with 24%, 13% and 12% lower hazard of occurrence of major toxicity respectively while every 10 point-increase in dyspnea (HR = and loss appetite was associated with 15% and 16% increased hazard of major toxicity.

Conclusion: Certain baseline HRQoL scores were found to be significantly associated with the occurrence of major toxicity.

Keywords: Head and neck cancer; Health related quality of life; Predictive factors.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Head and Neck Neoplasms* / radiotherapy
  • Humans
  • Prognosis
  • Quality of Life*
  • Surveys and Questionnaires